![Modeling COVID-19 transmission between age groups in the United States considering virus mutations, vaccinations, and reinfection | Scientific Reports Modeling COVID-19 transmission between age groups in the United States considering virus mutations, vaccinations, and reinfection | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-21559-9/MediaObjects/41598_2022_21559_Fig1_HTML.png)
Modeling COVID-19 transmission between age groups in the United States considering virus mutations, vaccinations, and reinfection | Scientific Reports
![Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination | Nature Reviews Immunology Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41577-021-00544-9/MediaObjects/41577_2021_544_Fig1_HTML.png)
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination | Nature Reviews Immunology
![Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021 | medRxiv Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021 | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/12/14/2020.12.13.20248120/F1.large.jpg)
Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021 | medRxiv
![PLS: Vaccination of poultry against highly pathogenic avian influenza – Available vaccines and vaccination strategies | EFSA PLS: Vaccination of poultry against highly pathogenic avian influenza – Available vaccines and vaccination strategies | EFSA](https://www.efsa.europa.eu/sites/default/files/styles/sm_col_12_fallback/public/2023-10/vaccination-of-poultry-pls.png.jpeg?itok=9gC20MFv)
PLS: Vaccination of poultry against highly pathogenic avian influenza – Available vaccines and vaccination strategies | EFSA
![Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study - The Lancet Infectious Diseases Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/089c31a4-b532-43f1-9873-0a7b62133674/gr1_lrg.jpg)
Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study - The Lancet Infectious Diseases
![Vaccinated or not, take steps to reduce risk of COVID-19 transmission – AZ Dept. of Health Services Director's Blog Vaccinated or not, take steps to reduce risk of COVID-19 transmission – AZ Dept. of Health Services Director's Blog](https://directorsblog.health.azdhs.gov/wp-content/uploads/2021/09/cloth-faces-5667x3200-1-1024x578.jpg)
Vaccinated or not, take steps to reduce risk of COVID-19 transmission – AZ Dept. of Health Services Director's Blog
![The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China | Infectious Diseases of Poverty | Full Text The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China | Infectious Diseases of Poverty | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40249-021-00922-4/MediaObjects/40249_2021_922_Fig5_HTML.png)
The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China | Infectious Diseases of Poverty | Full Text
![Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality - eClinicalMedicine Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality - eClinicalMedicine](https://www.thelancet.com/cms/asset/773c7eed-a8a0-4fe7-855d-7e88d62a41fd/gr1.jpg)
Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality - eClinicalMedicine
![Top 3 COVID-19 vaccine questions – Vaccines and stopping transmission, virus mutation and people who want to wait for vaccination | Australian Government Department of Health and Aged Care Top 3 COVID-19 vaccine questions – Vaccines and stopping transmission, virus mutation and people who want to wait for vaccination | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/videos/2021/05/top-3-covid-19-vaccine-questions-vaccines-and-stopping-transmission-virus-mutation-and-people-who-want-to-wait-for-vaccination.jpg)
Top 3 COVID-19 vaccine questions – Vaccines and stopping transmission, virus mutation and people who want to wait for vaccination | Australian Government Department of Health and Aged Care
![Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination](https://www.ecdc.europa.eu/sites/default/files/styles/is_large/public/images/Risk-of-transmission-and-reinfection-of-SARS-CoV-2-following-vaccination-cover.png?itok=HcBtzZGA)
Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination
![Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - ScienceDirect Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1473309921006484-gr1.jpg)